The risk of miscarriage is one of an expectant female’s worst concerns. This might occur as a result of pregnancy difficulties, or it can occur for no particular reason. However, if a doctor anticipates any issues that could lead to a tragedy, they may prescribe medications to maintain the smooth labor and birth.
However, researchers from the University of Texas Health Science Centre at Houston have discovered that one medication commonly used for this purpose may be detrimental to the unborn and may even raise the risk of some cancers in children.
17-hydroxyprogesterone caproate is the medication’s name (17-OHPC). During the late 1950s and early 1960s, this was a regular prescription. Many physicians still recommend this medication to avoid premature delivery. The main advantages of this medication are, it promotes uterus expansion and it protects a mother against pregnancy complications by preventing early contractions.
Based on some research, children born to mothers who used this medicine during maternity had a twofold increased risk of cancer throughout their lifespan in comparison to children born to mothers who chose not to take it. Pancreatic cancer, thyroid cancer, and a variety of other cancers were shown to be on the rise in those born around and after the 1960s. This incident caught their attention, so they looked into it more.
This artificial medication has the potential to alter a newborn’ initial stages. This is what makes you more likely to have cancer years later. Another prospective study found that using this medicine has no advantage and does not lower the chances of premature births.